VImpact
-
Class Notes
2000s Renee Iacona, PhD’08, has been named AstraZeneca’s chief operating officer for oncology R&D in addition to her role as vice president of oncology biometrics. 2010s Nicole Perry-Hauser Nicole Perry-Hauser, PhD’19, has accepted a position as a lecturer, on a research and teaching track, at the School of Molecular Biosciences… Read MoreDec. 11, 2024
-
Accolade corner
The hard work of the faculty, staff, postdocs, and graduate students who conduct basic biomedical research at Vanderbilt continues to be recognized on the local and national level. Here we list a few of the researchers who have been recently celebrated. Tina Iverson (Pharmacology) received an Innovation Catalyst Fund award… Read MoreDec. 11, 2024
-
Vanderbilt basic science alum Q&A: Sonja Fulmer
Sonja Fulmer, a graduate of Chemical and Physical Biology Program who is now the deputy director of the FDA’s Digital Health Center of Excellence, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her successful career. Read MoreDec. 10, 2024
-
School of Medicine Basic Sciences Staff Spotlight Roundup
By Alexandra Scammell The School of Medicine Basic Sciences consists of a remarkable community that is dedicated to advancing the study of human biology, health, and disease. In addition to the award-winning faculty and students who are at the forefront of our cutting-edge research, a large part of our school’s… Read MoreDec. 10, 2024
-
Faculty transitions
By Lorena Infante Lara The academic landscape can seem like an unmoving entity, but it’s the people within it that make it tick and grow to new frontiers. No outlook on our School of Medicine Basic Sciences is complete without recognizing significant faculty transitions, including well-deserved promotions, exciting new appointments,… Read MoreNov. 22, 2024